The COP9 signalosome controls ubiquitinylation of ABCA1

Biochemical and Biophysical Research Communications

Volumn 382, Issue 1, 2009, Pages 145-148

  Azuma, Yuya ^a   Takada, Mie ^a   Maeda, Minami ^a   Kioka, Noriyuki ^a   Ueda, Kazumitsu ^a,b  

^a KYOTO UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

ABCA1; Cholesterol; COP9 signalosome; CSN; Macrophage; Ubiquitin

Indexed keywords

ABC TRANSPORTER A1; APOLIPOPROTEIN A1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CHOLESTEROL; COP9 SIGNALOSOME; HIGH DENSITY LIPOPROTEIN; PROTEASOME; PROTEIN CSN2; PROTEIN CSN5; PROTEIN CSN7; PROTEIN CSN8; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VINCULIN;

ANIMAL CELL; ARTICLE; CELL STRAIN HEK293; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRECIPITATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UBIQUITINATION;

ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE; CHOLESTEROL; HUMANS; MACROPHAGES, PERITONEAL; MULTIPROTEIN COMPLEXES; PEPTIDE HYDROLASES; PROTEASOME ENDOPEPTIDASE COMPLEX; UBIQUITINATION;

EID: 63149154833     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.02.161     Document Type: Article

References (29)

1. Oram J.F., and Vaughan A.M. ATP-binding cassette cholesterol transporters and cardiovascular disease. Circ. Res. 99 (2006) 1031-1043
2. Yokoyama S. Release of cellular cholesterol: molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim. Biophys. Acta 1529 (2000) 231-244
3. Tanaka A.R., Abe-Dohmae S., Ohnishi T., Aoki R., Morinaga G., Okuhira K.I., Ikeda Y., Kano F., Matsuo M., Kioka N., Amachi T., Murata M., Yokoyama S., and Ueda K. Effects of mutations of ABCA1 in the first extracellular domain on subcellular trafficking and ATP binding/hydrolysis. J. Biol. Chem. 278 (2003) 8815-8819
4. Brooks-Wilson A., Marcil M., Clee S., Zhang L., Roomp K., van Dam M., Yu L., Brewer C., Collins J., Molhuizen H., Loubser O., Ouelette B., Fichter K., Ashbourne-Excoffon K., Sensen C., Scherer S., Mott S., Denis M., Martindale D., Frohlich J., Morgan K., Koop B., Pimstone S., Kastelein J., and Hayden M. Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency. Nat. Genet. 22 (1999) 336-345
5. Bodzioch M., Orso E., Klucken J., Langmann T., Bottcher A., Diederich W., Drobnik W., Barlage S., Buchler C., Porsch-Ozcurumez M., Kaminski W., Hahmann H., Oette K., Rothe G., Aslanidis C., Lackner K., and Schmitz G. The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease. Nat. Genet. 22 (1999) 347-351
6. Rust S., Rosier M., Funke H., Real J., Amoura Z., Piette J., Deleuze J., Brewer H., Duverger N., Denefle P., and Assmann G. Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1. Nat. Genet. 22 (1999) 352-355
7. Singaraja R.R., Brunham L.R., Visscher H., Kastelein J.J., and Hayden M.R. Efflux and atherosclerosis: the clinical and biochemical impact of variations in the ABCA1 gene. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1322-1332
8. Hozoji M., Munehira Y., Ikeda Y., Makishima M., Matsuo M., Kioka N., and Ueda K. Direct interaction of nuclear liver X receptor-beta with ABCA1 modulates cholesterol efflux. J. Biol. Chem. 283 (2008) 30057-30063
9. Munehira Y., Ohnishi T., Kawamoto S., Furuya A., Shitara K., Imamura M., Yokota T., Takeda S., Amachi T., Matsuo M., Kioka N., and Ueda K. Alpha1-syntrophin modulates turnover of ABCA1. J. Biol. Chem. 279 (2004) 15091-15095
10. Okuhira K., Fitzgerald M.L., Sarracino D.A., Manning J.J., Bell S.A., Goss J.L., and Freeman M.W. Purification of ATP-binding cassette transporter A1 and associated binding proteins reveals the importance of beta1-syntrophin in cholesterol efflux. J. Biol. Chem. 280 (2005) 39653-39664
11. Neufeld E.B., Remaley A.T., Demosky S.J., Stonik J.A., Cooney A.M., Comly M., Dwyer N.K., Zhang M., Blanchette-Mackie J., Santamarina-Fojo S., and Brewer Jr. H.B. Cellular localization and trafficking of the human ABCA1 transporter. J. Biol. Chem. 276 (2001) 27584-27590
12. Azuma Y., Takada M., Shin H.Y., Kioka N., Nakayama K., and Ueda K. Retroendocytosis pathway of ABCA1/apoA-I contributes to HDL formation. Genes Cells 14 (2009) 191-204
13. Arakawa R., and Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter A1 by protecting it from thiol protease-mediated degradation. J. Biol. Chem. 277 (2002) 22426-22429
14. Wang N., Chen W., Linsel-Nitschke P., Martinez L.O., Agerholm-Larsen B., Silver D.L., and Tall A.R. A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I. J. Clin. Invest. 111 (2003) 99-107
15. Lu R., Arakawa R., Ito-Osumi C., Iwamoto N., and Yokoyama S. ApoA-I facilitates ABCA1 recycle/accumulation to cell surface by inhibiting its intracellular degradation and increases HDL generation. Arterioscler. Thromb. Vasc. Biol. 28 (2008) 1820-1824
16. Feng B., and Tabas I. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. J. Biol. Chem. 277 (2002) 43271-43280
17. Schweitzer K., Bozko P.M., Dubiel W., and Naumann M. CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J. 26 (2007) 1532-1541
18. Cope G.A., Suh G.S., Aravind L., Schwarz S.E., Zipursky S.L., Koonin E.V., and Deshaies R.J. Role of predicted metalloprotease motif of Jab1/Csn5 in cleavage of Nedd8 from Cul1. Science 298 (2002) 608-611
19. Tsuge T., Matsui M., and Wei N. The subunit 1 of the COP9 signalosome suppresses gene expression through its N-terminal domain and incorporates into the complex through the PCI domain. J. Mol. Biol. 305 (2001) 1-9
20. Naumann M., Bech-Otschir D., Huang X., Ferrell K., and Dubiel W. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem. 274 (1999) 35297-35300
21. Denti S., Fernandez-Sanchez M.E., Rogge L., and Bianchi E. The COP9 signalosome regulates Skp2 levels and proliferation of human cells. J. Biol. Chem. 281 (2006) 32188-32196
22. Bianchi E., Denti S., Granata A., Bossi G., Geginat J., Villa A., Rogge L., and Pardi R. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404 (2000) 617-621
23. Yun J., Tomida A., Andoh T., and Tsuruo T. Interaction between glucose-regulated destruction domain of DNA topoisomerase IIalpha and MPN domain of Jab1/CSN5. J. Biol. Chem. 279 (2004) 31296-31303
24. Devries-Seimon T., Li Y., Yao P.M., Stone E., Wang Y., Davis R.J., Flavell R., and Tabas I. Cholesterol-induced macrophage apoptosis requires ER stress pathways and engagement of the type A scavenger receptor. J. Cell Biol. 171 (2005) 61-73
25. Li Y., Schwabe R.F., DeVries-Seimon T., Yao P.M., Gerbod-Giannone M.C., Tall A.R., Davis R.J., Flavell R., Brenner D.A., and Tabas I. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280 (2005) 21763-21772
26. Maxfield F.R., and Tabas I. Role of cholesterol and lipid organization in disease. Nature 438 (2005) 612-621
27. da Silva Correia J., Miranda Y., Leonard N., and Ulevitch R.J. The subunit CSN6 of the COP9 signalosome is cleaved during apoptosis. J. Biol. Chem. 282 (2007) 12557-12565
28. Wang L., Du F., and Wang X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133 (2008) 693-703
29. Yvan-Charvet L., Ranalletta M., Wang N., Han S., Terasaka N., Li R., Welch C., and Tall A.R. Combined deficiency of ABCA1 and ABCG1 promotes foam cell accumulation and accelerates atherosclerosis in mice. J. Clin. Invest. 117 (2007) 3900-3908